dsm-firmenich
dsm-firmenich boosts HMO portfolio
dsm-firmenich has announced that it has received ‘no questions’ response letters from the US Food and Drug Administration (FDA) to its Generally Recognized as Safe (GRAS) notices submitted by Glycom A/S* for three new human milk oligosaccharide (HMO) ingredients.
dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome
The transaction, as first announced on 19 April 2023, was completed for an enterprise value of €275 million.
Dsm-firmenich launches as innovator in nutrition, health, and beauty
Dsm-firmenich is excited to confirm the successful merger of DSM and Firmenich and the resulting launch of a new company that brings together one of the largest innovation and creation communities in nutrition, health, and beauty.
